Title |
Evidence synthesis and guideline development in genomic medicine: current status and future prospects
|
---|---|
Published in |
Genetics in Medicine, June 2014
|
DOI | 10.1038/gim.2014.69 |
Pubmed ID | |
Authors |
Sheri D. Schully, Tram Kim Lam, W. David Dotson, Christine Q. Chang, Naomi Aronson, Marian L. Birkeland, Stephanie Jo Brewster, Stefania Boccia, Adam H. Buchanan, Ned Calonge, Kathleen Calzone, Benjamin Djulbegovic, Katrina A.B. Goddard, Roger D. Klein, Teri E. Klein, Joseph Lau, Rochelle Long, Gary H. Lyman, Rebecca L. Morgan, Christina G.S. Palmer, Mary V. Relling, Wendy S. Rubinstein, Jesse J. Swen, Sharon F. Terry, Marc S. Williams, Muin J. Khoury |
Abstract |
With the accelerated implementation of genomic medicine, health-care providers will depend heavily on professional guidelines and recommendations. Because genomics affects many diseases across the life span, no single professional group covers the entirety of this rapidly developing field. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 50% |
Germany | 1 | 13% |
Unknown | 3 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Scientists | 2 | 25% |
Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 6% |
Unknown | 45 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 17% |
Other | 6 | 13% |
Student > Doctoral Student | 4 | 8% |
Professor > Associate Professor | 4 | 8% |
Student > Bachelor | 3 | 6% |
Other | 12 | 25% |
Unknown | 11 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 40% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Business, Management and Accounting | 2 | 4% |
Nursing and Health Professions | 2 | 4% |
Agricultural and Biological Sciences | 2 | 4% |
Other | 7 | 15% |
Unknown | 14 | 29% |